All the news articles and press releases in one place.


Date / Time Source Company % Chg Sector Market Cap Announcement
20Feb20 09:27 RNS Evgen Pharma -4.14% Health £4.60m Holding(s) in Company
13Feb20 07:00 RNS Evgen Pharma -4.14% Health £4.60m University of Rochester Collaboration
06Feb20 07:00 RNS Evgen Pharma -4.14% Health £4.60m University of Manchester collaboration discovery
20Jan20 15:39 RNS Evgen Pharma -4.14% Health £4.60m Holding(s) in Company
17Jan20 15:32 RNS Amati AIM VCT 0.00% Various Various Holding(s) in Company
08Jan20 09:52 RNS Amati AIM VCT 0.00% Various Various Holding(s) in Company
17Dec19 07:01 RNS-R Evgen Pharma -4.14% Health £4.60m Investor presentation
17Dec19 07:00 RNS Evgen Pharma -4.14% Health £4.60m Half-year Report
05Dec19 07:00 RNS Evgen Pharma -4.14% Health £4.60m MOU with The University of Dundee
04Dec19 15:11 RNS Evgen Pharma -4.14% Health £4.60m Notice of Results
14Nov19 11:59 RNS Evgen Pharma -4.14% Health £4.60m Holding(s) in Company
11Nov19 12:11 RNS Evgen Pharma -4.14% Health £4.60m SAS study clarification
11Nov19 07:00 RNS Evgen Pharma -4.14% Health £4.60m SFX-01 results in SAS study
30Sep19 07:00 RNS Evgen Pharma -4.14% Health £4.60m ESMO presentation of Phase II STEM clinical data
23Sep19 07:00 RNS Evgen Pharma -4.14% Health £4.60m Update on extended-use phase of STEM trial
05Sep19 07:00 RNS Evgen Pharma -4.14% Health £4.60m Agreement for supply of SFX-01 for autism trial
28Aug19 07:00 RNS Evgen Pharma -4.14% Health £4.60m Update on SAS study
07Aug19 07:00 RNS Evgen Pharma -4.14% Health £4.60m Grant of further European patent
05Aug19 07:00 RNS-R Evgen Pharma -4.14% Health £4.60m Research collaboration
25Jul19 13:00 RNS Evgen Pharma -4.14% Health £4.60m Grant of Options
18Jul19 15:47 RNS Evgen Pharma -4.14% Health £4.60m Result of AGM
18Jul19 07:00 RNS Evgen Pharma -4.14% Health £4.60m AGM Statement
24Jun19 07:00 RNS-R Evgen Pharma -4.14% Health £4.60m SFX-01 featured in SAH review paper
19Jun19 10:39 RNS Evgen Pharma -4.14% Health £4.60m Posting of Annual Report and AGM Notice
13Jun19 07:00 RNS Evgen Pharma -4.14% Health £4.60m Full Year Results
11Jun19 07:00 RNS Evgen Pharma -4.14% Health £4.60m Notification of Preliminary Results
22May19 13:32 RNS Evgen Pharma -4.14% Health £4.60m Holding(s) in Company
21May19 07:00 RNS Evgen Pharma -4.14% Health £4.60m Share Option Exercise and Issue of Equity
09May19 17:49 RNS Amati AIM VCT 0.00% Various Various Holding(s) in Company
09May19 10:11 RNS Evgen Pharma -4.14% Health £4.60m Holding(s) in Company
08May19 11:29 RNS Evgen Pharma -4.14% Health £4.60m Result of GM and Completion of Placing
26Apr19 11:05 RNS Evgen Pharma -4.14% Health £4.60m Second Price Monitoring Extn
24Apr19 11:37 RNS Evgen Pharma -4.14% Health £4.60m Holding(s) in Company
24Apr19 11:33 RNS Evgen Pharma -4.14% Health £4.60m Holding(s) in Company
23Apr19 14:05 RNS Evgen Pharma -4.14% Health £4.60m Second Price Monitoring Extn
23Apr19 10:30 RNS Evgen Pharma -4.14% Health £4.60m Holding(s) in Company
18Apr19 17:30 RNS Evgen Pharma -4.14% Health £4.60m Posting of Circular and Timing of General Meeting
17Apr19 13:00 RNS Evgen Pharma -4.14% Health £4.60m Placing and Notice of General Meeting
02Apr19 09:00 RNS-R Evgen Pharma -4.14% Health £4.60m finnCap publishes initiation research
28Mar19 07:00 RNS-R Evgen Pharma -4.14% Health £4.60m Poster presentation of Imperial College data
25Mar19 07:00 RNS Evgen Pharma -4.14% Health £4.60m SFX-01 meets primary endpoints in STEM trial
18Mar19 07:00 RNS Evgen Pharma -4.14% Health £4.60m Update on SFX-01 trial read-out dates
05Mar19 07:00 RNS Evgen Pharma -4.14% Health £4.60m SFX-01 data published in peer reviewed journal
06Feb19 15:30 RNS Evgen Pharma -4.14% Health £4.60m Holding(s) in Company
05Feb19 07:00 RNS Evgen Pharma -4.14% Health £4.60m Clinical trial update confirms read-outs on track
30Jan19 17:28 RNS Evgen Pharma -4.14% Health £4.60m Grant of Options
23Jan19 07:00 RNS-R Evgen Pharma -4.14% Health £4.60m SFX-01 featured in Nature Reviews Drug Discovery
22Jan19 07:00 RNS Evgen Pharma -4.14% Health £4.60m Change of Adviser
19Dec18 18:02 RNS Evgen Pharma -4.14% Health £4.60m Share option exercise and issue of equity
12Dec18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Interim Results
10Dec18 15:00 RNS Evgen Pharma -4.14% Health £4.60m Nominated Adviser Status
04Dec18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Poster Presentation of SFX-01 and Trial Update
03Dec18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Notification of Half Year Results
19Nov18 07:00 RNS-R Evgen Pharma -4.14% Health £4.60m Investor Presentation in Manchester
08Nov18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Directorate Changes
23Oct18 09:57 RNS Evgen Pharma -4.14% Health £4.60m Holding(s) in Company
18Oct18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Placing
18Sep18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Investor Symposium
11Sep18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Notice of Investor Symposium
26Jul18 15:22 RNS Evgen Pharma -4.14% Health £4.60m Result of AGM
26Jul18 07:00 RNS Evgen Pharma -4.14% Health £4.60m AGM Statement
25Jul18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Final Patient Recruited in STEM Phase IIa Trial
10Jul18 11:00 RNS Evgen Pharma -4.14% Health £4.60m Grant of share options, issue of equity and TVR
29Jun18 10:45 EQS Evgen Pharma -4.14% Health £4.60m Hardman & Co Research: Evgen Pharma (EVG): 2018, a pivotal year
21Jun18 12:30 RNS Evgen Pharma -4.14% Health £4.60m Posting of Annual Report and AGM Notice
13Jun18 14:15 EQS Evgen Pharma -4.14% Health £4.60m Hardman & Co Research: Evgen Pharma (EVG): Encouraging interim data from the STEM trial
13Jun18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Full Year Results
11Jun18 09:05 RNS Evgen Pharma -4.14% Health £4.60m Second Price Monitoring Extn
11Jun18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Interim Update on STEM Trial
07Jun18 16:40 RNS Evgen Pharma -4.14% Health £4.60m Second Price Monitoring Extn
30May18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Notification of Preliminary Results
02May18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Grant of further European patent
26Apr18 16:40 RNS Evgen Pharma -4.14% Health £4.60m Second Price Monitoring Extn
24Apr18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Presentation at World Orphan Drug Congress USA
20Mar18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Research Collaboration with Imperial College
05Mar18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Update on Novel Sulforaphane Analogues
15Jan18 07:00 RNS Evgen Pharma -4.14% Health £4.60m Poster Presentation of SFX-01 Mechanistic Data
10Jan18 16:31 RNS Evgen Pharma -4.14% Health £4.60m Notification of Major Interest in Shares
05Jan18 09:49 RNS Evgen Pharma -4.14% Health £4.60m Notification of Major Interest in Shares
05Jan18 09:48 RNS Evgen Pharma -4.14% Health £4.60m Notification of Major Interest in Shares
02Jan18 17:44 RNS Evgen Pharma -4.14% Health £4.60m Total Voting Rights
28Dec17 11:49 RNS Evgen Pharma -4.14% Health £4.60m Result of General Meeting
22Dec17 10:10 RNS Evgen Pharma -4.14% Health £4.60m Grant of Options
13Dec17 07:00 RNS Evgen Pharma -4.14% Health £4.60m Collaboration with King's College London
08Dec17 07:15 RNS Evgen Pharma -4.14% Health £4.60m Placing and Notice of General Meeting
08Dec17 07:00 RNS Evgen Pharma -4.14% Health £4.60m Interim Results
23Nov17 11:05 RNS Evgen Pharma -4.14% Health £4.60m Second Price Monitoring Extn
04Oct17 07:00 RNS Evgen Pharma -4.14% Health £4.60m First European Patent Grant
31Aug17 07:00 RNS Evgen Pharma -4.14% Health £4.60m Issue of Equity and Total Voting Rights
27Jul17 07:00 RNS Evgen Pharma -4.14% Health £4.60m Result of AGM
26Jul17 07:00 RNS Evgen Pharma -4.14% Health £4.60m AGM Statement
11Jul17 12:30 RNS Evgen Pharma -4.14% Health £4.60m Charity-funded Study of SFX-01 in TNBC
21Jun17 10:00 RNS Evgen Pharma -4.14% Health £4.60m Posting of Annual Report and AGM Notice
13Jun17 07:00 RNS Evgen Pharma -4.14% Health £4.60m Full Year Results
01Jun17 07:00 RNS Evgen Pharma -4.14% Health £4.60m Compassionate Use Programme and Trials Update
25May17 07:00 RNS Evgen Pharma -4.14% Health £4.60m Notice of Preliminary Results
03Apr17 14:15 RNS Evgen Pharma -4.14% Health £4.60m Directorate Change
28Mar17 14:45 RNS Evgen Pharma -4.14% Health £4.60m Further US Patent Grant
06Mar17 07:00 RNS Evgen Pharma -4.14% Health £4.60m Issue of Equity, PDMR Shareholding and TVR
14Feb17 13:30 RNS Evgen Pharma -4.14% Health £4.60m Patent Grant in the United States
Date / Time Source Company % Chg
20Feb20 09:27 RNS Evgen Pharma -4.14%
Holding(s) in Company
13Feb20 07:00 RNS Evgen Pharma -4.14%
University of Rochester Collaboration
06Feb20 07:00 RNS Evgen Pharma -4.14%
University of Manchester collaboration discovery
20Jan20 15:39 RNS Evgen Pharma -4.14%
Holding(s) in Company
17Jan20 15:32 RNS Amati AIM VCT 0.00%
Holding(s) in Company
08Jan20 09:52 RNS Amati AIM VCT 0.00%
Holding(s) in Company
17Dec19 07:01 RNS-R Evgen Pharma -4.14%
Investor presentation
17Dec19 07:00 RNS Evgen Pharma -4.14%
Half-year Report
05Dec19 07:00 RNS Evgen Pharma -4.14%
MOU with The University of Dundee
04Dec19 15:11 RNS Evgen Pharma -4.14%
Notice of Results
14Nov19 11:59 RNS Evgen Pharma -4.14%
Holding(s) in Company
11Nov19 12:11 RNS Evgen Pharma -4.14%
SAS study clarification
11Nov19 07:00 RNS Evgen Pharma -4.14%
SFX-01 results in SAS study
30Sep19 07:00 RNS Evgen Pharma -4.14%
ESMO presentation of Phase II STEM clinical data
23Sep19 07:00 RNS Evgen Pharma -4.14%
Update on extended-use phase of STEM trial
05Sep19 07:00 RNS Evgen Pharma -4.14%
Agreement for supply of SFX-01 for autism trial
28Aug19 07:00 RNS Evgen Pharma -4.14%
Update on SAS study
07Aug19 07:00 RNS Evgen Pharma -4.14%
Grant of further European patent
05Aug19 07:00 RNS-R Evgen Pharma -4.14%
Research collaboration
25Jul19 13:00 RNS Evgen Pharma -4.14%
Grant of Options
18Jul19 15:47 RNS Evgen Pharma -4.14%
Result of AGM
18Jul19 07:00 RNS Evgen Pharma -4.14%
AGM Statement
24Jun19 07:00 RNS-R Evgen Pharma -4.14%
SFX-01 featured in SAH review paper
19Jun19 10:39 RNS Evgen Pharma -4.14%
Posting of Annual Report and AGM Notice
13Jun19 07:00 RNS Evgen Pharma -4.14%
Full Year Results
11Jun19 07:00 RNS Evgen Pharma -4.14%
Notification of Preliminary Results
22May19 13:32 RNS Evgen Pharma -4.14%
Holding(s) in Company
21May19 07:00 RNS Evgen Pharma -4.14%
Share Option Exercise and Issue of Equity
09May19 17:49 RNS Amati AIM VCT 0.00%
Holding(s) in Company
09May19 10:11 RNS Evgen Pharma -4.14%
Holding(s) in Company
08May19 11:29 RNS Evgen Pharma -4.14%
Result of GM and Completion of Placing
26Apr19 11:05 RNS Evgen Pharma -4.14%
Second Price Monitoring Extn
24Apr19 11:37 RNS Evgen Pharma -4.14%
Holding(s) in Company
24Apr19 11:33 RNS Evgen Pharma -4.14%
Holding(s) in Company
23Apr19 14:05 RNS Evgen Pharma -4.14%
Second Price Monitoring Extn
23Apr19 10:30 RNS Evgen Pharma -4.14%
Holding(s) in Company
18Apr19 17:30 RNS Evgen Pharma -4.14%
Posting of Circular and Timing of General Meeting
17Apr19 13:00 RNS Evgen Pharma -4.14%
Placing and Notice of General Meeting
02Apr19 09:00 RNS-R Evgen Pharma -4.14%
finnCap publishes initiation research
28Mar19 07:00 RNS-R Evgen Pharma -4.14%
Poster presentation of Imperial College data
25Mar19 07:00 RNS Evgen Pharma -4.14%
SFX-01 meets primary endpoints in STEM trial
18Mar19 07:00 RNS Evgen Pharma -4.14%
Update on SFX-01 trial read-out dates
05Mar19 07:00 RNS Evgen Pharma -4.14%
SFX-01 data published in peer reviewed journal
06Feb19 15:30 RNS Evgen Pharma -4.14%
Holding(s) in Company
05Feb19 07:00 RNS Evgen Pharma -4.14%
Clinical trial update confirms read-outs on track
30Jan19 17:28 RNS Evgen Pharma -4.14%
Grant of Options
23Jan19 07:00 RNS-R Evgen Pharma -4.14%
SFX-01 featured in Nature Reviews Drug Discovery
22Jan19 07:00 RNS Evgen Pharma -4.14%
Change of Adviser
19Dec18 18:02 RNS Evgen Pharma -4.14%
Share option exercise and issue of equity
12Dec18 07:00 RNS Evgen Pharma -4.14%
Interim Results
10Dec18 15:00 RNS Evgen Pharma -4.14%
Nominated Adviser Status
04Dec18 07:00 RNS Evgen Pharma -4.14%
Poster Presentation of SFX-01 and Trial Update
03Dec18 07:00 RNS Evgen Pharma -4.14%
Notification of Half Year Results
19Nov18 07:00 RNS-R Evgen Pharma -4.14%
Investor Presentation in Manchester
08Nov18 07:00 RNS Evgen Pharma -4.14%
Directorate Changes
23Oct18 09:57 RNS Evgen Pharma -4.14%
Holding(s) in Company
18Oct18 07:00 RNS Evgen Pharma -4.14%
Placing
18Sep18 07:00 RNS Evgen Pharma -4.14%
Investor Symposium
11Sep18 07:00 RNS Evgen Pharma -4.14%
Notice of Investor Symposium
26Jul18 15:22 RNS Evgen Pharma -4.14%
Result of AGM
26Jul18 07:00 RNS Evgen Pharma -4.14%
AGM Statement
25Jul18 07:00 RNS Evgen Pharma -4.14%
Final Patient Recruited in STEM Phase IIa Trial
10Jul18 11:00 RNS Evgen Pharma -4.14%
Grant of share options, issue of equity and TVR
29Jun18 10:45 EQS Evgen Pharma -4.14%
Hardman & Co Research: Evgen Pharma (EVG): 2018, a pivotal year
21Jun18 12:30 RNS Evgen Pharma -4.14%
Posting of Annual Report and AGM Notice
13Jun18 14:15 EQS Evgen Pharma -4.14%
Hardman & Co Research: Evgen Pharma (EVG): Encouraging interim data from the STEM trial
13Jun18 07:00 RNS Evgen Pharma -4.14%
Full Year Results
11Jun18 09:05 RNS Evgen Pharma -4.14%
Second Price Monitoring Extn
11Jun18 07:00 RNS Evgen Pharma -4.14%
Interim Update on STEM Trial
07Jun18 16:40 RNS Evgen Pharma -4.14%
Second Price Monitoring Extn
30May18 07:00 RNS Evgen Pharma -4.14%
Notification of Preliminary Results
02May18 07:00 RNS Evgen Pharma -4.14%
Grant of further European patent
26Apr18 16:40 RNS Evgen Pharma -4.14%
Second Price Monitoring Extn
24Apr18 07:00 RNS Evgen Pharma -4.14%
Presentation at World Orphan Drug Congress USA
20Mar18 07:00 RNS Evgen Pharma -4.14%
Research Collaboration with Imperial College
05Mar18 07:00 RNS Evgen Pharma -4.14%
Update on Novel Sulforaphane Analogues
15Jan18 07:00 RNS Evgen Pharma -4.14%
Poster Presentation of SFX-01 Mechanistic Data
10Jan18 16:31 RNS Evgen Pharma -4.14%
Notification of Major Interest in Shares
05Jan18 09:49 RNS Evgen Pharma -4.14%
Notification of Major Interest in Shares
05Jan18 09:48 RNS Evgen Pharma -4.14%
Notification of Major Interest in Shares
02Jan18 17:44 RNS Evgen Pharma -4.14%
Total Voting Rights
28Dec17 11:49 RNS Evgen Pharma -4.14%
Result of General Meeting
22Dec17 10:10 RNS Evgen Pharma -4.14%
Grant of Options
13Dec17 07:00 RNS Evgen Pharma -4.14%
Collaboration with King's College London
08Dec17 07:15 RNS Evgen Pharma -4.14%
Placing and Notice of General Meeting
08Dec17 07:00 RNS Evgen Pharma -4.14%
Interim Results
23Nov17 11:05 RNS Evgen Pharma -4.14%
Second Price Monitoring Extn
04Oct17 07:00 RNS Evgen Pharma -4.14%
First European Patent Grant
31Aug17 07:00 RNS Evgen Pharma -4.14%
Issue of Equity and Total Voting Rights
27Jul17 07:00 RNS Evgen Pharma -4.14%
Result of AGM
26Jul17 07:00 RNS Evgen Pharma -4.14%
AGM Statement
11Jul17 12:30 RNS Evgen Pharma -4.14%
Charity-funded Study of SFX-01 in TNBC
21Jun17 10:00 RNS Evgen Pharma -4.14%
Posting of Annual Report and AGM Notice
13Jun17 07:00 RNS Evgen Pharma -4.14%
Full Year Results
01Jun17 07:00 RNS Evgen Pharma -4.14%
Compassionate Use Programme and Trials Update
25May17 07:00 RNS Evgen Pharma -4.14%
Notice of Preliminary Results
03Apr17 14:15 RNS Evgen Pharma -4.14%
Directorate Change
28Mar17 14:45 RNS Evgen Pharma -4.14%
Further US Patent Grant
06Mar17 07:00 RNS Evgen Pharma -4.14%
Issue of Equity, PDMR Shareholding and TVR
14Feb17 13:30 RNS Evgen Pharma -4.14%
Patent Grant in the United States
Date / Time Company % Chg
20Feb20 09:27 Evgen Pharma -4.14%
Holding(s) in Company
13Feb20 07:00 Evgen Pharma -4.14%
University of Rochester Collaboration
06Feb20 07:00 Evgen Pharma -4.14%
University of Manchester collaboration discovery
20Jan20 15:39 Evgen Pharma -4.14%
Holding(s) in Company
17Jan20 15:32 AMAT LSE,EVG LSE 0.00%
Holding(s) in Company
08Jan20 09:52 AMAT LSE,EVG LSE 0.00%
Holding(s) in Company
17Dec19 07:01 Evgen Pharma -4.14%
Investor presentation
17Dec19 07:00 Evgen Pharma -4.14%
Half-year Report
05Dec19 07:00 Evgen Pharma -4.14%
MOU with The University of Dundee
04Dec19 15:11 Evgen Pharma -4.14%
Notice of Results
14Nov19 11:59 Evgen Pharma -4.14%
Holding(s) in Company
11Nov19 12:11 Evgen Pharma -4.14%
SAS study clarification
11Nov19 07:00 Evgen Pharma -4.14%
SFX-01 results in SAS study
30Sep19 07:00 Evgen Pharma -4.14%
ESMO presentation of Phase II STEM clinical data
23Sep19 07:00 Evgen Pharma -4.14%
Update on extended-use phase of STEM trial
05Sep19 07:00 Evgen Pharma -4.14%
Agreement for supply of SFX-01 for autism trial
28Aug19 07:00 Evgen Pharma -4.14%
Update on SAS study
07Aug19 07:00 Evgen Pharma -4.14%
Grant of further European patent
05Aug19 07:00 Evgen Pharma -4.14%
Research collaboration
25Jul19 13:00 Evgen Pharma -4.14%
Grant of Options
18Jul19 15:47 Evgen Pharma -4.14%
Result of AGM
18Jul19 07:00 Evgen Pharma -4.14%
AGM Statement
24Jun19 07:00 Evgen Pharma -4.14%
SFX-01 featured in SAH review paper
19Jun19 10:39 Evgen Pharma -4.14%
Posting of Annual Report and AGM Notice
13Jun19 07:00 Evgen Pharma -4.14%
Full Year Results
11Jun19 07:00 Evgen Pharma -4.14%
Notification of Preliminary Results
22May19 13:32 Evgen Pharma -4.14%
Holding(s) in Company
21May19 07:00 Evgen Pharma -4.14%
Share Option Exercise and Issue of Equity
09May19 17:49 AMAT LSE,EVG LSE 0.00%
Holding(s) in Company
09May19 10:11 Evgen Pharma -4.14%
Holding(s) in Company
08May19 11:29 Evgen Pharma -4.14%
Result of GM and Completion of Placing
26Apr19 11:05 Evgen Pharma -4.14%
Second Price Monitoring Extn
24Apr19 11:37 Evgen Pharma -4.14%
Holding(s) in Company
24Apr19 11:33 Evgen Pharma -4.14%
Holding(s) in Company
23Apr19 14:05 Evgen Pharma -4.14%
Second Price Monitoring Extn
23Apr19 10:30 Evgen Pharma -4.14%
Holding(s) in Company
18Apr19 17:30 Evgen Pharma -4.14%
Posting of Circular and Timing of General Meeting
17Apr19 13:00 Evgen Pharma -4.14%
Placing and Notice of General Meeting
02Apr19 09:00 Evgen Pharma -4.14%
finnCap publishes initiation research
28Mar19 07:00 Evgen Pharma -4.14%
Poster presentation of Imperial College data
25Mar19 07:00 Evgen Pharma -4.14%
SFX-01 meets primary endpoints in STEM trial
18Mar19 07:00 Evgen Pharma -4.14%
Update on SFX-01 trial read-out dates
05Mar19 07:00 Evgen Pharma -4.14%
SFX-01 data published in peer reviewed journal
06Feb19 15:30 Evgen Pharma -4.14%
Holding(s) in Company
05Feb19 07:00 Evgen Pharma -4.14%
Clinical trial update confirms read-outs on track
30Jan19 17:28 Evgen Pharma -4.14%
Grant of Options
23Jan19 07:00 Evgen Pharma -4.14%
SFX-01 featured in Nature Reviews Drug Discovery
22Jan19 07:00 Evgen Pharma -4.14%
Change of Adviser
19Dec18 18:02 Evgen Pharma -4.14%
Share option exercise and issue of equity
12Dec18 07:00 Evgen Pharma -4.14%
Interim Results
10Dec18 15:00 Evgen Pharma -4.14%
Nominated Adviser Status
04Dec18 07:00 Evgen Pharma -4.14%
Poster Presentation of SFX-01 and Trial Update
03Dec18 07:00 Evgen Pharma -4.14%
Notification of Half Year Results
19Nov18 07:00 Evgen Pharma -4.14%
Investor Presentation in Manchester
08Nov18 07:00 Evgen Pharma -4.14%
Directorate Changes
23Oct18 09:57 Evgen Pharma -4.14%
Holding(s) in Company
18Oct18 07:00 Evgen Pharma -4.14%
Placing
18Sep18 07:00 Evgen Pharma -4.14%
Investor Symposium
11Sep18 07:00 Evgen Pharma -4.14%
Notice of Investor Symposium
26Jul18 15:22 Evgen Pharma -4.14%
Result of AGM
26Jul18 07:00 Evgen Pharma -4.14%
AGM Statement
25Jul18 07:00 Evgen Pharma -4.14%
Final Patient Recruited in STEM Phase IIa Trial
10Jul18 11:00 Evgen Pharma -4.14%
Grant of share options, issue of equity and TVR
29Jun18 10:45 Evgen Pharma -4.14%
Hardman & Co Research: Evgen Pharma (EVG): 2018, a pivotal year
21Jun18 12:30 Evgen Pharma -4.14%
Posting of Annual Report and AGM Notice
13Jun18 14:15 Evgen Pharma -4.14%
Hardman & Co Research: Evgen Pharma (EVG): Encouraging interim data from the STEM trial
13Jun18 07:00 Evgen Pharma -4.14%
Full Year Results
11Jun18 09:05 Evgen Pharma -4.14%
Second Price Monitoring Extn
11Jun18 07:00 Evgen Pharma -4.14%
Interim Update on STEM Trial
07Jun18 16:40 Evgen Pharma -4.14%
Second Price Monitoring Extn
30May18 07:00 Evgen Pharma -4.14%
Notification of Preliminary Results
02May18 07:00 Evgen Pharma -4.14%
Grant of further European patent
26Apr18 16:40 Evgen Pharma -4.14%
Second Price Monitoring Extn
24Apr18 07:00 Evgen Pharma -4.14%
Presentation at World Orphan Drug Congress USA
20Mar18 07:00 Evgen Pharma -4.14%
Research Collaboration with Imperial College
05Mar18 07:00 Evgen Pharma -4.14%
Update on Novel Sulforaphane Analogues
15Jan18 07:00 Evgen Pharma -4.14%
Poster Presentation of SFX-01 Mechanistic Data
10Jan18 16:31 Evgen Pharma -4.14%
Notification of Major Interest in Shares
05Jan18 09:49 Evgen Pharma -4.14%
Notification of Major Interest in Shares
05Jan18 09:48 Evgen Pharma -4.14%
Notification of Major Interest in Shares
02Jan18 17:44 Evgen Pharma -4.14%
Total Voting Rights
28Dec17 11:49 Evgen Pharma -4.14%
Result of General Meeting
22Dec17 10:10 Evgen Pharma -4.14%
Grant of Options
13Dec17 07:00 Evgen Pharma -4.14%
Collaboration with King's College London
08Dec17 07:15 Evgen Pharma -4.14%
Placing and Notice of General Meeting
08Dec17 07:00 Evgen Pharma -4.14%
Interim Results
23Nov17 11:05 Evgen Pharma -4.14%
Second Price Monitoring Extn
04Oct17 07:00 Evgen Pharma -4.14%
First European Patent Grant
31Aug17 07:00 Evgen Pharma -4.14%
Issue of Equity and Total Voting Rights
27Jul17 07:00 Evgen Pharma -4.14%
Result of AGM
26Jul17 07:00 Evgen Pharma -4.14%
AGM Statement
11Jul17 12:30 Evgen Pharma -4.14%
Charity-funded Study of SFX-01 in TNBC
21Jun17 10:00 Evgen Pharma -4.14%
Posting of Annual Report and AGM Notice
13Jun17 07:00 Evgen Pharma -4.14%
Full Year Results
01Jun17 07:00 Evgen Pharma -4.14%
Compassionate Use Programme and Trials Update
25May17 07:00 Evgen Pharma -4.14%
Notice of Preliminary Results
03Apr17 14:15 Evgen Pharma -4.14%
Directorate Change
28Mar17 14:45 Evgen Pharma -4.14%
Further US Patent Grant
06Mar17 07:00 Evgen Pharma -4.14%
Issue of Equity, PDMR Shareholding and TVR
14Feb17 13:30 Evgen Pharma -4.14%
Patent Grant in the United States